South Africa has suspended the roll-out of Oxford/AstraZeneca COVID-19 vaccine over limited protection against new coronavirus variant.
Fossil fuel is expected to dominate Africa’s energy mix by the end of the decade.
AstraZeneca has said that its vaccine being developed in collaboration with the University of Oxford could be 90% effective.
The experimental vaccine being developed by AstraZeneca Plc produced a robust immune response in older adults and the elderly.
After concerns on safety triggered a pause, AstraZeneca has resumed clinical trial of it's vaccine.
The human trials of the Oxford vaccine are expected to be through in September.